Kai Cenat has officially announced the return of Streamer University, opening applications for the 2026 class as the Twitch star continues his comeback after stepping away from regular streaming for ...

Priority Waste is apologizing to customers for recent service disruptions and says it has already taken steps aimed at improving reliability and response times. In a letter sent to customers, the ...

Priority Waste hired a new CEO who is expected to address service issues. The company took over a large number of contracts locally after it acquired GFL. The service disruptions have lingered since ...

Nearly four months after parting ways with its founder and CEO, Metro Detroit's most prominent waste hauler has a new boss and a new parent company. Priority Waste announced Monday the appointment of ...

NEW YORK – Bayer said on Monday that the US Food and Drug Administration granted priority review to its application seeking approval for Hyrnuo (sevabertinib) as a first-line treatment for ...

WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer announced today that the U.S. Food and Drug Administration (FDA) has granted HYRNUO ® (sevabertinib) Priority Review status for the first-line treatment of adult ...

May 4 (Asia Today) --Seoul accounted for more than 80% of first-priority apartment subscription applications in South Korea in March, according to an analysis by real estate platform Zigbang. Zigbang ...

WashU Overseas Programs has implemented priority applications for the fall and spring 2027 spring study abroad application cycle due to capacity constraints of popular study abroad destinations, ...

– Novel Investigational Combination Pairs Bictegravir, Guideline-Recommended INSTI with High Barrier to Resistance, with Lenacapavir, a First-in-Class Capsid Inhibitor, Designed for Sustained ...

U.S. FDA Grants Priority Review of New Drug Application for Gilead’s Once-Daily HIV Treatment of Bictegravir Plus Lenacapavir – Novel Investigational Combination Pairs Bictegravir, ...

NEW YORK – Jazz Pharmaceuticals on Monday said the US Food and Drug Administration has accepted its biologics license application seeking approval for Ziihera (zanidatamab) as part of first-line ...